Advertisement Quigley names CFO and director - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quigley names CFO and director

The Quigley Corporation, a manufacturer of homeopathic and health products, has announced that Gerard Gleeson has been named to succeed George Longo, who will be retiring from the company on September 5, 2008, as vice president, CFO and as a member of the board of directors.

Mr Gleeson joined The Quigley Corporation in 1998 and has served in management positions including corporate controller of the company since 2004.

Mr Gleeson’s career includes his tenure as CFO in Ireland for a subsidiary of Allergan. Additionally, Mr Gleeson has senior financial management experience in the retail and service industries.

Guy Quigley, chairman, president and CEO, said: “George Longo has served as CFO and a director of the company since 1997 and played a vital role in The Quigley’s successes throughout the years. We are sorry to see him leave and appreciate all of his contributions to the company and wish him well in his retirement.”